Method for inhibiting interleukin-2 production using tricyclo compounds
US6482845B1 · kind B1 · utility
1Cited by
14References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2000 |
| Grant date | Nov 19, 2002 |
| Priority date | — |
| Expiry date | Nov 27, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/898
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to tricyclo compounds useful for treatment and prevention of resistance by transplantation, graft-versus-host diseases by medulla ossium transplantation, autoimmune diseases, infectious diseases, and the like, which can be represented by the following formula: to a process for their production, to a pharmaceutical composition containing the same and to a use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.